Authors:
Mocroft, A
Phillips, AN
Miller, V
Gatell, J
van Lunzen, J
Parkin, JM
Weber, R
Roge, B
Lazzarin, A
Lundgren, JD
Citation: A. Mocroft et al., The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study, AIDS, 15(2), 2001, pp. 201-209
Citation: O. Degen et al., Intensification of background antiretroviral therapy with abacavir during low-level failure may restore optimal suppression, ANTIVIR TH, 5(2), 2000, pp. 91-94
Authors:
Eggers, C
Stuerenburg, HJ
Schafft, T
Zollner, B
Feucht, HH
Stellbrink, HJ
van Lunzen, J
Citation: C. Eggers et al., Rapid clearance of human immunodeficiency virus type 1 from ventricular cerebrospinal fluid during antiretroviral treatment, ANN NEUROL, 47(6), 2000, pp. 816-819
Authors:
Paredes, R
Mocroft, A
Kirk, O
Lazzarin, A
Barton, SE
van Lunzen, J
Katzenstein, TL
Antunes, F
Lundgren, JD
Clotet, B
Citation: R. Paredes et al., Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe - Results fromthe EuroSIDA Study, ARCH IN MED, 160(8), 2000, pp. 1123-1132
Authors:
Eggers, CC
van Lunzen, J
Buhk, T
Stellbrink, HJ
Citation: Cc. Eggers et al., HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in cerebrospinal fluid, J ACQ IMM D, 20(3), 1999, pp. 259-264
Authors:
Ruiz, L
van Lunzen, J
Arno, A
Stellbrink, HJ
Schneider, C
Rull, M
Castella, E
Ojanguren, I
Richman, DD
Clotet, B
Tenner-Racz, K
Citation: L. Ruiz et al., Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue, AIDS, 13(1), 1999, pp. F1-F8
Authors:
Zhang, LQ
Lewin, SR
Markowitz, M
Lin, HH
Skulsky, E
Karanicolas, R
He, YX
Jin, X
Tuttleton, S
Vesanen, M
Spiegel, H
Kost, R
van Lunzen, J
Stellbrink, HJ
Wolinsky, S
Borkowsky, W
Palumbo, P
Kostrikis, LG
Ho, DD
Citation: Lq. Zhang et al., Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy, J EXP MED, 190(5), 1999, pp. 725-732
Authors:
Miller, V
Mocroft, A
Reiss, P
Katlama, C
Papadopoulos, AI
Katzenstein, T
van Lunzen, J
Antunes, F
Phillips, AN
Lundgren, JD
Citation: V. Miller et al., Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: Results from the EuroSIDA study, ANN INT MED, 130(7), 1999, pp. 570-577
Authors:
Stellbrink, HJ
Hufert, FT
Tenner-Racz, K
Lauer, J
Schneider, C
Albrecht, H
Racz, P
van Lunzen, J
Citation: Hj. Stellbrink et al., Kinetics of productive and latent HIV infection in lymphatic tissue and peripheral blood during triple-drug combination therapy with or without additional interleukin-2, ANTIVIR TH, 3(4), 1998, pp. 209-214